06 February 2013 20:13 [Source: ICIS news]
Correction: In the ICIS news story headlined "US INVISTA, Arzeda enter agreement to develop bio-BD" dated 6 February 2013, please read in the second paragraph … INVISTA produces adiponitrile (ADN)… instead of … INVISTA produces adipic acid…. A corrected story follows.
HOUSTON (ICIS)--INVISTA and Arzeda have entered into an agreement to develop bio-based butadiene (BD) and other feedstock, the US-based companies said on Wednesday.
INVISTA produces adiponitrile (ADN), which uses BD as a feedstock.
“As we seek innovative solutions to increase the global supply of butadiene, we believe developing a cost-competitive bio-derived route will help assure ample supply and reduce price volatility,” said Bill Greenfield, executive vice president of INVISTA’s nylon intermediates business, in a company statement.
Under the agreement, INVISTA and Arzeda will collaborate to develop each of their bio-based technologies with the ultimate goal of developing bio-based processes for several products, the companies said. The initial focus will be on bio-BD.
INVISTA already has capabilities and biotechnology and catalysis, the companies said. Arzeda designs enzymes.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections